In what is a major win for Amazon.com (NASDAQ: AMZN ) , the online retailer said in a press release that it signed up more than 1 million new customers for Amazon Prime in the third week of December alone, adding to its approximate 16.7 million members it had after the first week of that month. The final numbers for new signups in December haven't been released yet, but it looks good for Amazon heading into 2014.
According to a report from Consumer Intelligence Research Partners, Amazon Prime members spend "$1,340 per year, compared to $708 per year for non-Amazon Prime customers," accounting for "56% of US product sales."
The $632 spread would account for more than $632 million in new sales if the differential between Amazon Prime and regular Amazon customers holds. That's a huge catalyst, and one that should continue to grow in the years ahead. And these numbers are low, considering they don't take into account the busy last week before Christmas.
That's good news for Amazon investors, as it is definitely a nice moat that differentiates Amazon from its competitors. Amazon Prime costs $79 per year and offers those signing up for the service free two-day shipping, along with access to streaming-video content.
10 Best Building Product Stocks To Invest In 2015: USell.com Inc (USEL)
usell.com, Inc. (uSel), formerly known as Upstream Worldwide, Inc., incorporated on November 18, 2003, is a technology-based company. The Company focuses on creating an online marketplace where individuals interested in selling small consumer electronics.
The Company through its wholly owned subsidiaries helps individuals monetize household items. Household items, such as small consumer electronics that they no longer using.
The Company competes with eBay.com, craigslist.com and BestBuy, Inc.
Advisors' Opinion:- [By EquityOptionsGuru]
Over the past decade, online marketplaces have been springing up at a rapid fire pace.� Consumers continue to seek new outlets to both buy and sell products at reasonable prices with high efficiency.� This need can be seen in the re-commerce industry, which represents an annual market of $57 billion.� Although eBay (NASDAQ: EBAY) has been the dominant player for the better part of a decade, it is facing increasing pressure from other marketplaces for cost and convenience reasons.� One such marketplace, uSell.com (OTC PINK: USEL), appears poised to rival eBay for years to come.
Top 5 Shipping Companies To Watch For 2014: Honda Motor Company Ltd. (HMC)
Honda Motor Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and distribution of motorcycles, automobiles, and power products primarily in North America, Europe, and Asia. Its motorcycle line consists of business and commuter models, as well as sports models, including trial and moto-cross racing; all?terrain vehicles; personal watercrafts; and multi utility vehicles. The company also produces various automobile products, including passenger cars, minivans, multi-wagons, sport utility vehicles, and mini cars; and power products comprising tillers, portable generators, general-purpose engines, grass cutters, outboard marine engines, water pumps, snow throwers, power carriers, power sprayers, lawn mowers and lawn tractors, home-use cogeneration units, and thin film solar cells for home, public, and industrial uses. In addition, it sells spare parts and provides after sales services are through retail dealers, as well as offers retail lendin g and leasing to customers, and wholesale financing to dealers. The company was founded in 1946 and is based in Tokyo, Japan.
Advisors' Opinion:- [By John Rosevear]
A nice story in a huge market segment for Ford
To be clear, the success of the all-new Escape is nothing to sneeze at. Ford officials noted�on Wednesday that the Escape was the compact SUV class sales leader in the first quarter, outselling its longtime nemesis, Honda's (NYSE: HMC ) popular CR-V. - [By Dan Caplinger]
2. You won't get as many promotional financing deals.
Many auto dealers offer low-cost loans as an incentive to buy. Over the years, Ford (NYSE: F ) , General Motors (NYSE: GM ) , and Chrysler all offered great financing deals to compete with more popular Japanese models. With Detroit now having rebounded, Honda (NYSE: HMC ) and Toyota (NYSE: TM ) have also renewed incentives that include financing deals. Even now, Ford offers 0% financing on some of its popular models, including the Focus pictured above. - [By John Rosevear]
In many ways, Honda's (NYSE: HMC ) subcompact Fit is a classic Honda: It's small and fuel-efficient, but roomy and well-thought-out, with an endearing look that owners love. But the current car is reaching the end of its life, and competitors like Ford's (NYSE: F ) Fiesta have arguably outpaced it in some ways.
- [By Paul Ausick]
Honda Motor Co. Ltd. (NYSE: HMC) reported fiscal�third-quarter results last Friday. In the quarter the company sold 900,000 units, a year-over-year increase of 7%. Auto sales revenue rose 23.9%. The company said it expects to sell 1.6 million cars in the United States in 2014. January sales data will not be released until after markets close Monday.
Top 5 Shipping Companies To Watch For 2014: Taro Pharmaceutical Industries Ltd (TARO)
Taro Pharmaceutical Industries Ltd., incorporated in 1959, is a science-based pharmaceutical company. The Company develops manufactures, and markets prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. The Company also develops and manufactures active pharmaceutical ingredients (APIs), primarily for use in its finished dosage form products. The Company�� primary areas of focus include pediatric creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through three companies: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries (including indirect), Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets more than 180 pharmaceutical products in over 25 countries.
Taro Israel manufactures more than 160 finished dosage form pharmaceutical products for sale in Israel and for export. It produces APIs used in the manufacture of finished dosage form pharmaceutical products. It markets and distributes generic products in the local Israeli market. Taro Israel�� primary product lines include dermatology, prescription and OTC semi-solid products (creams, ointments and gels) and liquids; cardiology and neurology, prescription oral dosage products; oral analgesics, both prescription and OTC, and OTC oral and nasal sprays and ophthalmic products.
Taro Canada manufactures more than 70 finished dosage form pharmaceutical products for sale in Canada and for export. It markets and distributes generic products in the local Canadian market. Its product line includes dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology, oncology, gastrointestinal and neurology: prescription oral and injects able dosage products, and allergy (antihistamine): OTC oral dosage products.
Taro U.S.A markets! and distributes generic products in the United States market. Its primary product lines include dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology and neurology: prescription oral dosage products, and other prescription and OTC products.
The Company competes with Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer/Wyeth, Valeant, Galderma, Merck/Schering-Plough, Teva Pharmaceuticals U.S.A., Mylan Laboratories, Perrigo Company, Ranbaxy Pharmaceuticals Inc., Sandoz Pharmaceuticals, Merck Canada Inc., Pfizer Canada Inc., Janssen Inc., Schering-Plough Canada, Novartis Pharmaceuticals Canada Inc., GlaxoSmithKline Inc., Bayer Inc., Bristol-Myers Squibb Canada, Apotex Inc., Teva Canada Limited, Mylan Pharmaceuticals ULC, Sandoz Canada Incorporated, Pharmascience Inc., Teva Pharmaceutical Industries Ltd., Perrigo Israel Pharmaceuticals Ltd., Dexxon Ltd., Rafa Laboratories Ltd., Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and Pfizer Inc.
Advisors' Opinion:- [By Ben Levisohn]
Teva has dropped 7.7% to $37.85 today at 3:23 p.m. but doesn’t seem to be spreading though the generic drug space. Taro Pharmaceuticals (TARO) ha gained 1.1% to $79, while Actavis (ACT) has gained 1.2% to $156.25 and Dr. Reddy’s Laboratories (RDY) has advanced 1% to $40.24. Mylan (MYL) has dropped 0.7% to $38.40.
Top 5 Shipping Companies To Watch For 2014: HomeServe PLC (HSV)
Homeserve plc is a United Kingdom-based company engaged in the provision of home emergency repairs. The Company operates in five segments: UK, USA, Domeo, Spain, and New Markets. Its products cover plumbing and drains, central heating, ventilation and air conditioning, electrics and household appliances, such as showers and boilers. The Company provides home emergency and repair services to over 4.9 million customers across businesses in the United Kingdom, the United States, France and Spain. It also has developing businesses in Italy, Germany and France. The Company�� subsidiaries include HomeServe Assistance Limited, HomeServe Enterprises Limited, HomeServe International Limited, HomeServe Membership Limited and Reparalia Direct SL. Advisors' Opinion:- [By Sarah Jones]
Homeserve Plc (HSV) climbed 8.1 percent to 265.6 pence. Liberum Capital said the company may attract private-equity buyers after reporting its full-year results. The company may soon complete its discussions with the financial-services regulator about inappropriate sales practices.
No comments:
Post a Comment